Examinant per Autoria "Nathan, Steven D."
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension(Wiley, 2022) Nikkho, Sylvia M.; Richter, Manuel J.; Shen, Eric; Abman, Steven H.; Antoniou, Katerina; Chung, Jonathan; Fernandes, Peter; Hassoun, Paul; Lazarus, Howard M.; Olschewski, Horst; Piccari, Lucilla; Psotka, Mitchell; Saggar, Rajan; Shlobin, Oksana A.; Stockbridge, Norman; Vitulo, Patrizio; Vizza, Carmine Dario; Wort, Stephen John; Nathan, Steven D.
Ítem Accés Obert Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension(Wiley, 2023) Piccari, Lucilla; Allwood, Brian; Antoniou, Katerina; Chung, Jonathan; Hassoun, Paul; Nikkho, Sylvia M.; Saggar, Rajan; Shlobin, Oksana A.; Vitulo, Patrizio; Nathan, Steven D.; Wort, Stephen John
Ítem Accés Obert Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension(Wiley, 2022) Nathan, Steven D.; Fernandes, Peter; Psotka, Mitchell; Vitulo, Patrizio; Piccari, Lucilla; Antoniou, Katerina; Nikkho, Sylvia M.; Stockbridge, Norman
Ítem Accés Obert Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension(Wiley, 2024) Shlobin, Oksana A.; Shen, Eric; Wort, Stephen John; Piccari, Lucilla; Scandurra, John A.; Hassoun, Paul; Nikkho, Sylvia M.; Nathan, Steven D.